drug · protein
efineptakin alfa
Phase 2updated 3mo agoby NeoImmuneTech Inc🔗 ChEMBL
Phase 2community read0 votes
Protein drug with a maximum clinical stage of Phase 2 (across all indications), with 5 investigational indications.
indications
indications
NSCLCColorectal Cancer
all catalysts(0)
nothing on the calendar yet
Trials studying efineptakin alfa
- phase2Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
- phase1Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy
- phase1NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery
- phase2NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that